Investigation of arrhythmias in anthropomorphized murine cardiac myocytes.
拟人化小鼠心肌细胞心律失常的研究。
基本信息
- 批准号:7690884
- 负责人:
- 金额:$ 3.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-15 至 2011-08-14
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsArrhythmiaBehaviorCalciumCalcium ChannelCardiacCardiac MyocytesCellsCessation of lifeComputational BiologyComputational TechniqueComputer SimulationCouplesDevelopmentDiseaseElectrophysiology (science)ElementsEngineeringEventFutureGenetically Engineered MouseHealthHeart ArrestHeart DiseasesHumanHybridsIn VitroInduced MutationInheritedInvestigationIon ChannelKineticsLeadLong QT SyndromeMasksMediatingMembraneMembrane PotentialsMethodsModelingMorphologyMusMuscle CellsMutant Strains MiceMutationNational Heart, Lung, and Blood InstitutePatch-Clamp TechniquesPatientsPhenotypeProtocols documentationRunningSimulateStagingStrategic PlanningStudy modelsSyncopeTechniquesTimeValidationWild Type Mousedisease-causing mutationexperienceheart cellheart rhythmhuman diseaseinsightmathematical modelmouse modelmutantnovelresearch studyresponsesudden cardiac deaththeoriesvoltage
项目摘要
DESCRIPTION (provided by applicant): This application presents and utilizes a new electrophysiology technique, the anthropomorphizing dynamic clamp (ADC) that increases the utility of genetically engineered mice in studies of inherited cardiac arrhythmias. Inherited channelopathies, such as the Long QT syndrome, are known causes of syncope, cardiac arrest, and sudden cardiac death. In the past decade, great progress has been made in identifying disease-causing mutations in patients. Several mouse models of these mutations have been produced; however, extrapolation of a mouse mutant phenotype to human disease is difficult because of the major differences between mouse and human cardiac electrophysiology dynamics. The technique proposed in this application uses a hybrid computational biology-electrophysiology method in order to examine isolated mouse myocytes in the context of a human action potential waveform. The ADC is a dynamic whole-cell patch clamp technique that couples an isolated murine cardiac myocyte to computational models. These models calculate a compensatory current which will allow a mouse myocyte to undergo a free-running human membrane potential. This will permit investigation of arrhythmogenic events, such as early after depolarizations, which are normally masked in the context of the short mouse action potential. Preliminary modeling studies have demonstrated that the ADC can be used to study the effects of a mutation introduced into a mouse myocyte on the human action potential. The ADC could be applied to a wide-range of mouse models of inherited channelopathies. Also, it is directly relevant to the NHLBI strategic plan, which specifically calls for the development of computational and experimental techniques that can help uncover the pathophysiologic mechanisms of cardiac diseases. Lay Summary: Disturbances in the normal rhythm of the heart (arrhythmias) can lead to serious health consequences, including death. Some people have inherited mutations which increase the likelihood of arrhythmias. Genetically engineered mice have been made in order to study these mutations; however, major differences exist between mouse and human heart rhythms. The new technique proposed in this application will convert the behavior of mouse heart cells to a more human-like state. Studies of mice using this technique should yield new insights into the mechanisms of heart rhythm diseases.
描述(由申请人提供):本申请提出并利用了一种新的电生理学技术,拟人化动态钳(ADC),该技术增加了遗传性心律失常研究中基因工程小鼠的效用。遗传性通道病,如长QT综合征,是晕厥、心脏骤停和心源性猝死的已知原因。在过去的十年中,在确定患者的致病突变方面取得了很大进展。已经产生了这些突变的几种小鼠模型;然而,由于小鼠和人类心脏电生理动力学之间的主要差异,将小鼠突变表型外推到人类疾病是困难的。本申请中提出的技术使用混合计算生物学-电生理学方法,以便在人类动作电位波形的背景下检查分离的小鼠肌细胞。ADC是一种动态全细胞膜片钳技术,将分离的小鼠心肌细胞与计算模型偶联。这些模型计算补偿电流,其将允许小鼠肌细胞经历自由运行的人膜电位。这将允许研究致心律失常事件,例如早期后去极化,其通常在短小鼠动作电位的背景下被掩蔽。初步建模研究表明,ADC可用于研究引入小鼠肌细胞的突变对人类动作电位的影响。ADC可应用于广泛的遗传性通道病小鼠模型。此外,它与NHLBI战略计划直接相关,该计划特别要求开发计算和实验技术,以帮助揭示心脏疾病的病理生理机制。简单总结:正常心律失常(心律失常)可能导致严重的健康后果,包括死亡。有些人遗传了突变,增加了心律失常的可能性。为了研究这些突变,已经制造了基因工程小鼠;然而,小鼠和人类心律之间存在重大差异。这项应用中提出的新技术将把小鼠心脏细胞的行为转变为更像人类的状态。使用这种技术对小鼠进行的研究应该会对心律疾病的机制产生新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca Clare Ahrens-Nicklas其他文献
Rebecca Clare Ahrens-Nicklas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rebecca Clare Ahrens-Nicklas', 18)}}的其他基金
Network modulation to improve gene therapy in CLN3 disease
网络调节改善 CLN3 疾病的基因治疗
- 批准号:
10579621 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Disease Severity Stratification in Multiple Sulfatase Deficiency
多种硫酸酯酶缺乏症的疾病严重程度分层
- 批准号:
10700164 - 财政年份:2022
- 资助金额:
$ 3.78万 - 项目类别:
Disease Severity Stratification in Multiple Sulfatase Deficiency
多种硫酸酯酶缺乏症的疾病严重程度分层
- 批准号:
10513906 - 财政年份:2022
- 资助金额:
$ 3.78万 - 项目类别:
Network modulation to improve gene therapy in CLN3 disease
网络调节改善 CLN3 疾病的基因治疗
- 批准号:
10626675 - 财政年份:2022
- 资助金额:
$ 3.78万 - 项目类别:
The 2021 Multiple Sulfatase Deficiency Scientific and Family Meeting
2021 年多种硫酸酯酶缺乏症科学和家庭会议
- 批准号:
10318766 - 财政年份:2021
- 资助金额:
$ 3.78万 - 项目类别:
Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
- 批准号:
9789984 - 财政年份:2018
- 资助金额:
$ 3.78万 - 项目类别:
Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
- 批准号:
10004182 - 财政年份:2018
- 资助金额:
$ 3.78万 - 项目类别:
Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
- 批准号:
10457437 - 财政年份:2018
- 资助金额:
$ 3.78万 - 项目类别:
Mechanisms of neuronal network dysfunction in juvenile neuronal ceroid lipofuscinosis
幼年神经元蜡质脂褐质沉积症神经元网络功能障碍的机制
- 批准号:
10248394 - 财政年份:2018
- 资助金额:
$ 3.78万 - 项目类别:
Investigation of arrhythmias in anthropomorphized murine cardiac myocytes.
拟人化小鼠心肌细胞心律失常的研究。
- 批准号:
7544841 - 财政年份:2008
- 资助金额:
$ 3.78万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 3.78万 - 项目类别:














{{item.name}}会员




